PPARG and Hypoglycemia: For example, metformin demonstrates protective effects on bone by inhibiting PPAR-γ, thereby promoting bone formation and reducing resorption (Feng et al., 2021), the use of sulfonylureas is associated with an increased risk of falls and fractures due to hypoglycemia (Zhang et al., 2020).